New national guidelines say millions more Americans should get screened for lung cancer. The test can save lives, but it's inaccessible to many and harmful to some. How should we balance the promise and perils of lung cancer screening?

Guests:

Otis Brawley, MD, Professor of Oncology, Johns Hopkins University School of Medicine

Lisa Carter-Harris, PhD, APRN, Behavioral Scientist and Adult Nurse Practitioner, Memorial Sloan Kettering Cancer Center

Cherie Erkmen, MD, Professor of Thoracic Surgery and Director, Lung Cancer Screening Program, Temple University

Ella Kazerooni, MD, Professor of Radiology, University of Michigan

Ida Pittman, lung cancer patient, Temple University Hospital 

Helena Price, Ida’s cousin and health care advocate

Gerard Silvestri, MD, Professor of Pulmonology, Medical University of South Carolina

Dig deeper into the research and tradeoffs of lung cancer screening on our website: https://tradeoffs.org/2021/05/27/catching-americas-top-cancer-killer/

Read a transcript of this episode: https://tradeoffs.org/2021/05/27/catching-americas-top-cancer-killer-transcript/

Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletter

Support this type of journalism today, with a gift: https://tradeoffs.org/donate

Follow us on Twitter: https://twitter.com/tradeoffspod

Hosted on Acast. See acast.com/privacy for more information.